287 related articles for article (PubMed ID: 2963741)
21. Renal effects of synthetic rat-atrial natriuretic peptide in nephron-reduced rats with nephrotoxic nephritis.
Nitta K; Sanaka T; Kawaguchi H; Tsuchiya K; Sone M; Takuma T; Sugino N
Jpn J Exp Med; 1987 Feb; 57(1):41-5. PubMed ID: 2957529
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneous renal responses to atrial natriuretic factor. II. Cirrhotic dogs.
Maher E; Cernacek P; Levy M
Am J Physiol; 1989 Nov; 257(5 Pt 2):R1068-74. PubMed ID: 2531553
[TBL] [Abstract][Full Text] [Related]
23. Diuretic response of a second infusion of atrial natriuretic polypeptide into anesthetized dogs.
Akabane S; Matsushima Y; Kawamura M; Kojima S; Ito K
Nephron; 1987; 45(2):135-9. PubMed ID: 2951604
[TBL] [Abstract][Full Text] [Related]
24. Effect of atrial natriuretic peptide on the release of rat renal kallikrein.
Klein HG; Schöneck V; Obika LF; Odigie P; Angchanpen P; Marin-Grez M
Miner Electrolyte Metab; 1989; 15(3):130-6. PubMed ID: 2524641
[TBL] [Abstract][Full Text] [Related]
25. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
Schafferhans K; Heidbreder E; Hummel S; Heidland A
Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
[TBL] [Abstract][Full Text] [Related]
26. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome.
Hisanaga S; Yamamoto Y; Kida O; Kato J; Fujimoto S; Tanaka K
Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385
[TBL] [Abstract][Full Text] [Related]
27. Modulation of the natriuretic response to atrial natriuretic peptide by alterations in peritubular Starling forces in the rat.
Mendez RE; Dunn BR; Troy JL; Brenner BM
Circ Res; 1986 Dec; 59(6):605-11. PubMed ID: 2949885
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoids potentiate the action of atrial natriuretic polypeptide in adrenalectomized rats.
Hayamizu S; Kanda K; Ohmori S; Murata Y; Seo H
Endocrinology; 1994 Dec; 135(6):2459-64. PubMed ID: 7988432
[TBL] [Abstract][Full Text] [Related]
29. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
30. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
[TBL] [Abstract][Full Text] [Related]
31. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
[TBL] [Abstract][Full Text] [Related]
32. Effects of a physiological dose of ANP on renal function in dogs.
Banks RO
Am J Physiol; 1988 Nov; 255(5 Pt 2):F907-10. PubMed ID: 2973245
[TBL] [Abstract][Full Text] [Related]
33. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
[TBL] [Abstract][Full Text] [Related]
34. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention.
La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P
Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983
[TBL] [Abstract][Full Text] [Related]
35. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
Caron N; Kramp R
Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
[TBL] [Abstract][Full Text] [Related]
36. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
[TBL] [Abstract][Full Text] [Related]
37. The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor.
Hansell P; Fasching A; Sjöquist M; Andén NE; Ulfendahl HR
Acta Physiol Scand; 1987 Jul; 130(3):401-7. PubMed ID: 2957892
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing vascular and natriuretic responses to ANP.
Torikai S
Jpn Circ J; 1988 Dec; 52(12):1450-2. PubMed ID: 2977196
[TBL] [Abstract][Full Text] [Related]
39. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
40. Atrial natriuretic peptide induces sustained natriuresis in conscious dogs.
Mizelle HL; Hildebrandt DA; Gaillard CA; Brands MW; Montani JP; Smith MJ; Hall JE
Am J Physiol; 1990 Jun; 258(6 Pt 2):R1445-52. PubMed ID: 2141770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
